Shayan Mohammadmoradi: Excited to Co-Chair the 2028 Hemostasis Gordon Research Seminar
Shayan Mohammadmoradi, Vascular Biology and Platelet Function Scientist at University of Kentucky, CEO at Moradi Enterprise, shared a post on LinkedIn:
”What a fantastic week at the 2026 Hemostasis GRS/C! The science, discussions, collaborations, and friendships made this an unforgettable experience.
I am especially excited to share that my good friend and colleague Ana Sachetto and I have been selected as the incoming Co-Chairs of the 2028 Hemostasis Gordon Research Seminar!
We are honored by the opportunity and already looking forward to creating an engaging, inclusive, and memorable program for the next generation of our field.
A huge thank you to the Chairs and Vice Chairs of the 2026 GRC for creating such a phenomenal program.
See you in 2028 and stay tuned!”
Stay updated with Hemostasis Today.
-
Aug 7, 2026, 16:04Ayuka King-Percival: Understanding Platelet Aggregation Testing
-
Aug 7, 2026, 15:59Nita Radhakrishnan։ New Evidence-Based Guidelines for Transfusion-Dependent Thalassemia
-
Aug 7, 2026, 15:54Seema Dawood: Why the Peripheral Blood Smear Still Matters in the Age of Automation?
-
Aug 7, 2026, 15:42Mohammed Elmourtada Abdulgayoom։ Caplacizumab-Enabled Treatment of iTTP Without Plasma Exchange
-
Aug 7, 2026, 15:40Renata Evertz: THUNDER Study Sets a New Benchmark in Stroke Thrombectomy
-
Aug 7, 2026, 15:23Ashley Brown: An Incredible Week at the Hemostasis GRC
-
Aug 7, 2026, 15:04Danique Steeghs: Developing a Chip-Sized ADAMTS13 Activity Assay for TTP Point-of-Care Testing
-
Aug 7, 2026, 15:02Mohd Laraib: The Importance of Multidisciplinary Collaboration in the Management of CAPS
-
Aug 7, 2026, 15:02Sip Wijchers: How PFA Technology Influences Hemolysis and Renal Safety